With a 10mg/mL vial, 2.5mg equals 25 units
However, the lack of FDA approval and oversight for the final compounded products introduces inherent risks. Douglas Ewing, MD, FACS, DABOM Concerns have been raised about the potential for contamination, impurities, and incorrect dosages in some compounded products, Ewing continued
The speed at which tirzepatide works at standard doses reflects this full dual activation
GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes
Of the ZEPBOUND-treated patients in OSA clinical studies, 37.2% and 19.5% of patients developed antibodies that were cross reactive to native GIP and native GLP-1, respectively
I am very happy with your product so far